The New Funding Model Summary. The Global Fund. (2013)

Core New_Funding_Model_Summary_2013

A transition to the new funding model is underway. Access to funding in the transition phase is by invitation, and special consideration will be given to countries in a position to achieve rapid impact, those at risk of service interruptions, and those currently receiving less than they would under the new funding model’s allocation principles. There is diversity across regions and diseases and types of applicants, so that elements of the new funding model can be tested and refined. 

 

 

Download this publication

IF 101 - Key Information on the HIV Investment Framework (IF). APCASO, Australian Federation of AIDS Organisations, and CAI Country Partners China HIV/AIDS Information Network. (2013)

immage

The HIV Investment Framework (IF) is a model for HIV and AIDS investment and prioritisation for maximum impact. The IF advocates for a short-term increase in HIV funding in order to reduce funding requirements over the long term. IF is aligned to the investment thinking approach to resourcing of the HIV response. This means treating resources for the HIV response as investments that will deliver returns, rather than as expenses that will always have gaps demanding to be filled.

Download Publication

Transaction Prices for Antiretroviral Medicines from 2010 to 2013: WHO AIDS Medicines and Diagnostics Services: Global Price Reporting Mechanism: Summary Report. WHO. (2013)

immage

This summary report is intended to provide the pricing data of key ARVs to governments, nongovernmental organizations, donors, international organizations, academia and individuals or institutions directly involved or interested in the procurement of ARVs in resource-poor settings.


Keywords: HIV, drug, economics, infections, therapy

Download Publication

Smart Investments. UNAIDS. (2013)

immage

HIV investment cases provide an important vehicle for countries to deliver strategic, rights-based, sustainable responses to HIV. The process of developing investment cases provides countries with new opportunities to explore options for innovative funding and service delivery, to identify specific steps to enhance equity and inclusiveness for key populations, to use available evidence to understand better the health and economic benefits of timely, rights-based, smart HIV investments and to eliminate inefficiency in HIV programmes.

Download Publication

Evaluation of a Decade of DFID and World Bank Supported HIV and AIDS Programmes in Vietnam from 2003 to 2012. Zhang L, Maher L, Pham QD, et al. (2013)

immage

This report provides the findings of a comprehensive evaluation on the implementation, management, estimated population impacts, and cost-effectiveness of the DFID and the World Bank funded harm reduction programmes in Vietnam. It mainly included three major components: (1) an extensive literature review of legal and policy documents to understand key changes in the legal and policy environment in Vietnam; (2) a qualitative study utilising focus groups with key stakeholders and programme participants to provide background and context for understanding the implementation, management and effectiveness of the DFID/WB programmes; (3) a quantitative assessment of population impacts and cost-effectiveness of DFID/WB programmes based on a mathematical model.

Download Publication

Return on Investment and Cost-Effectiveness of Harm Reduction Programme in Malaysia. Naning H, Kerr C, Kamarulzaman A, et al. (2013)

immage

This project aimed to assess whether the harm reduction programme in Malaysia, which consists of NSP and MMT programmes amongst PWID, have been cost-effective from the perspective of the government by estimating savings in direct health care cost to the government resulting from infections that were averted as a result of the NSP and MMT programmes. The following estimates were included in the estimate of savings in direct health care costs; estimate the cost-effectiveness of the NSP and MMT programmes in terms of costs for the provision of programmes net of health care cost savings for each quality-adjusted-life years (QALYs) gained; estimate the return on investment (ROI) from NSP and MMT programmes where ROI refers to total health care costs saved from averted infections in comparison to total programme costs.


Keywords: HIV, AIDS, needles, syringes, PWID, estimates, infections

Download Publication

National AIDS Spending Assessment (NASA IV) in Cambodia: Years of Assessment: 2011 and 2012. Nitsoy A. (2013)

immage

NASA team always aims to collect expenditure data from all actors of the response. These organizations – actors of the HIV response – are playing different roles in different transactions, either financial or in-kind. The organization acts as a Financing Source when it makes money available for the country’s HIV response. It transfers funds to the other organizations who decide what should be implemented and who will be implementing. This role is a role of a Financing.

Download Publication

Indonesia National AIDS Spending Assessment 2011-2012. Nadjib M, Megraini A, Ishardini L and Rosalina L. (2013)

immage

HIV and AIDS are among health issues prioritized in the Millenium Development Goals (MDGs) and require considerable attention from various stakeholders. The Government of Indonesia, along with international partners has been working hard in suppressing the spread of AIDS in the country through various programs. However, more challenges remain, and despite considerable amount of money spent in resources to combat HIV and AIDS in Indonesia, the rate of new cases of HIV continue to persist.

 

Keywords: NASA, expenditures, spending, prevention, treatment, vulnerable

Download Publication

Financing the Response to AIDS in Low- and Middle- Income Countries: International Assistance from Donor Governments in 2011. Kates J, Wexler A, Lief E and Gobet B. (2012).

2012 Financing_response_to_AIDS_in_low_and_middle_income_countries_in_2011-1

This report is based on analysis of data provided by the 23 donor government members of the Organisation for Economic Co-operation and Development (OECD)’s Development Assistance Committee (DAC) and the European Union (EU). It includes their combined bilateral assistance and contributions to the Global Fund to Fight AIDS, Tuberculosis and Malaria (the Global Fund) and to UNITAID. 

 

 

Download this publication

Sri Lanka: National AIDS Spending Assessment 2009-2010. Colombo, Institute for Health Policy and National STD/AIDS Control Programme Ministry of Health (2012)

Sri Lanka_National_AIDS_Spending_Assessment

Tracking of national HIV expenditures and financing flows are an essential requirement to monitor and plan the resources for tackling HIV. The National AIDS Spending Assessment (NASA) tool, assists to monitor these scarce resources for HIV, considering not just the health components, but also education, social protection services, and others, in order to evaluate and quantify the multi-sectoral approach of the national AIDS response. NASA will help to identify funding gaps and duplication of funding in the national response to HIV epidemic.

This publication provides estimates of overall HIV spending in the country for the years 2009–2010, and will be of much value to the Ministry of Health (MOH), as well as the stakeholders who are interested in understanding the financial flows of the national AIDS response.

 

 

 

Download this publication

Pages

database
Highlighted publications
http://aidsdatahub.org/sites/default/files/highlight-reference/document/WHO_HIV_drug_resistance_report_2017.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/WHO_Guidelines_on_public_health_response_to_pretreatment_HIV_drug_resistance_2017.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/WHO_Guidelines_for_Managing_Advanced_HIV_Disease_and_Rapid_Initiation_of_ART_2017.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/WHO_What_New_in_Treatment_Monitoring_Viral_Load_and_CD4_Testing_2017.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/Pakistan_IBBS_2016-17.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/Pakistan_Mapping_Key_Populations_2015-16.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/UNAIDS_Global_AIDS_Update_2017.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/UNAIDS_Global_AIDS_Update_2017_Data_2017_en.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/Myanmar_National_Strategic_Plan_on_HIV_and_AIDS_2016-2020.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/UNAIDS_2017_Global_AIDS_Monitoring_2016.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/Nepal-IBBS-FIDU-Kathmandu-valley-RI-2016.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/NEC_HIV_May-AIDSreg2017.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/UNAIDS_methods_for_deriving_estimates_2016.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/2015_Size_Estimation_of_Key_Affected_Populations_in_Philippines.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/Assessment_of_Decentralization_of_ART_in_MMR_2016.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/UNAIDS-2016-prevention-gap-report_en.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/UNAIDS_Biomedical_AIDS_research_2016.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/Implementing_comprehensive_HIV_and_STI_programmes_with_transgender_people_2016.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/UNAIDS_cities_ending_the_aids_epidemic_2016.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/Philippines_2015_IHBSS_Factsheets.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/WHO_Integrating_collaborative_TB_and_HIV_services_within_a_comprehensive_package_of_care_for_PWID_2016.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/India_IBBS_report_2014-15.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/India_HSS_report_2014-15.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/2015_young_people_drugs_en.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/Transforming_our_world_2015_UN.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/WHO_Consolidated_on_the_use_of_antiretroviral_drugs_for_treating_and_preventing_HIV_infection_2016.pdf
Calendar of events
Oct
11
Nov
14
Nov
20